Literature DB >> 11176859

Advances in biomedical imaging.

C M Tempany1, B J McNeil.   

Abstract

In the 21st century, diseases will be diagnosed and treated using increasingly less invasive, more sophisticated imaging and image-guided procedures. During the past 100 years, the field of biomedical imaging has developed from Roentgen's original discovery of the x-ray to the imaging tools of today, such as magnetic resonance imaging, computed tomography, positron emission tomography, and ultrasonography. The benefits of using these sophisticated noninvasive imaging tools are already evident: more accurate and timely diagnosis of disease has translated into improved patient care. Recent advances in imaging research have shown the potential to change many aspects of clinical medicine within the next decade. Major new areas of research focus on development of the molecular, functional, cellular, and genetic imaging tools of the future, aided by new information technology and image fusion/integration capabilities. Image-guided therapy is growing rapidly, with advances in computer science, technology, and noninvasive treatment methods, such as focused ultrasonography. Undoubtedly, these and other new imaging techniques will enhance the ability to accurately diagnose and recognize disease and allow understanding of the molecular mechanisms of diseases and their respective responses to therapy. Given this explosion in new technologies, the next 25 years promise to result in dramatic changes in diagnostic imaging, particularly with respect to detection and recognition of disease.

Entities:  

Mesh:

Year:  2001        PMID: 11176859     DOI: 10.1001/jama.285.5.562

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  19 in total

1.  Predictive genetic tests and health system costs.

Authors:  Steve Morgan; Jeremiah Hurley; Fiona Miller; Mita Giacomini
Journal:  CMAJ       Date:  2003-04-15       Impact factor: 8.262

Review 2.  [The role of pelvic lymphadenectomy in clinically localised prostate cancer].

Authors:  M Schumacher; F C Burkhard; U E Studer
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

3.  Internal pilots for a class of linear mixed models with Gaussian and compound symmetric data.

Authors:  Matthew J Gurka; Christopher S Coffey; Keith E Muller
Journal:  Stat Med       Date:  2007-09-30       Impact factor: 2.373

4.  Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes.

Authors:  Annelie Maass; Peter Lundh von Leithner; Vy Luong; Li Guo; Thomas E Salt; Frederick W Fitzke; M Francesca Cordeiro
Journal:  Curr Eye Res       Date:  2007-10       Impact factor: 2.424

Review 5.  Molecular imaging will replace myocardial perfusion imaging.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2008 May-Jun       Impact factor: 5.952

6.  Factors affecting patient compliance in the acute setting: an analysis of 20,000 imaging reports.

Authors:  Waqas Shuaib; Arvind Vijayasarathi; Jamlik-Omari Johnson; Ninad Salastekar; Qing He; Kiran Kumar Maddu; Faisal Khosa
Journal:  Emerg Radiol       Date:  2014-03-11

7.  Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Authors:  Christopher D Corso; Arif N Ali; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2011-01-25       Impact factor: 6.166

8.  Determination of adequate pelvic lymph node dissection range for Japanese males undergoing radical prostatectomy.

Authors:  Nobuki Furubayashi; Takahito Negishi; Hidenori Iwai; Kei Nagase; Kenichi Taguchi; Mototsugu Shimokawa; Motonobu Nakamura
Journal:  Mol Clin Oncol       Date:  2017-03-28

9.  Will molecular optical imaging have clinically important roles in stroke management, and how?

Authors:  Dong Kun Lee; Matthias Nahrendorf; Dawid Schellingerhout; Dong-Eog Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

Review 10.  Extended lymph node dissection for prostate cancer.

Authors:  Stephan Jeschke; Fiona C Burkhard; Ramesh Thurairaja; Nivedita Dhar; Urs E Studer
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.